title: CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.
abstract: OBJECTIVE
  CpG oligodeoxynucleotides (CpG-ODN) are being investigated as cancer vaccine adjuvants because they mature plasmacytoid dendritic cells (PDC) into potent antigen-presenting cells. CpG-ODN also induce PDC to secrete chemokines that alter lymphocyte migration. Whether CpG-ODN TLR signals enhance antigen-specific immunity and/or trafficking in humans is unknown.
  
  
  METHODS
  We conducted a phase I study of CpG-ODN (1018 ISS) given as a vaccine adjuvant with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce T-cell immunity to a peptide vaccine from the tumor-associated antigen hTERT.
  
  
  RESULTS
  The adjuvant effect was limited; only 1 of 16 patients showed a high-frequency hTERT-specific tetramer CD8(+) T-cell response. However, CpG-ODN induced marked, transient peripheral blood lymphopenia. Biopsies showed dense lymphocytic infiltration at the vaccine site clustered around activated PDC. In vitro, CpG-ODN-treated PDC induced T-cell migration, showing that CpG-ODN stimulation of human PDC was sufficient to chemoattract T cells.
  
  
  CONCLUSIONS
  Our results show that (a) CpG-ODN with GM-CSF may not be an effective adjuvant strategy for hTERT peptide vaccines but (b) GM-CSF/CpG-ODN causes a PDC-mediated chemokine response that recruits T-cell migration to the peripheral tissues. These findings suggest a novel therapeutic role for targeted injections of CpG-ODN to direct lymphocyte migration to specific sites such as the tumor bed.
authors.affiliation: Department of Hematology/Oncology, Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
authors.forename: W Nicholas
authors.initials: WN
authors.lastname: Haining
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Davies
authors.forename: Holger
authors.initials: H
authors.lastname: Kanzler
authors.forename: Linda
authors.initials: L
authors.lastname: Drury
authors.forename: Thomas
authors.initials: T
authors.lastname: Brenn
authors.forename: John
authors.initials: J
authors.lastname: Evans
authors.forename: Jill
authors.initials: J
authors.lastname: Angelosanto
authors.forename: Steven
authors.initials: S
authors.lastname: Rivoli
authors.forename: Kate
authors.initials: K
authors.lastname: Russell
authors.forename: Suzanne
authors.initials: S
authors.lastname: George
authors.forename: Paul
authors.initials: P
authors.lastname: Sims
authors.forename: Donna
authors.initials: D
authors.lastname: Neuberg
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Li
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Kutok
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Morgan
authors.forename: Patrick
authors.initials: P
authors.lastname: Wen
authors.forename: George
authors.initials: G
authors.lastname: Demetri
authors.forename: Robert L
authors.initials: RL
authors.lastname: Coffman
authors.forename: Lee M
authors.initials: LM
authors.lastname: Nadler